Present and Future Insights Into The Pathogenesis of Cancer-Associat…

Cleveland Clinic Dermatology & Plastic Surgery Institute

D. Fiorentino

Management of Raynaud’s Phenomenon

John D. Pauling

Vasculitis Treatment Update

Keck School of Medicine of USC

K. Ruddy

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

Cleveland Clinic Rheumatic Case Studies: 32 y/o Male w/ Inflammatory…

Cleveland Clinic Rheumatology

L. Calabrese, J. Gelfand, C. Oddis, J. Cush, A. Kavanaugh, R. Hajj-Ali

Are There Factors That Can Guide Treatment Decisions in Newly Diagno…

Cleveland Clinic Rheumatology

A. Villa-Forte

Dermatologic Manifestations in Rheumatic Diseases

Saakshi Khattri

Refractory GERD: Diagnosis and Management - What Happens When PPIs D…

Rush University Medical Center

R. Abraham

Giant Cell Arteritis in the Arab Region With a Focus on Jordan

Fatima Al Naimat

Management of Pulmonary Fibrosis in Clinical Practice

National Jewish Health

J. Solomon

Update on the Management of GERD

ACG 2023 Conference Coverage

S. Spechler

Myths and Misconceptions ANCA Associated Vasculitis

RheumNow

M. Putman

Rheumatology Update for the Generalist in 2024

McMaster University Department of Medicine

R. Mirza

Diagnosis and Treatment of Idiopathic Inflammatory Myositis: What Ar…

Johns Hopkins Rheumatology

C. Mecoli

Myositis ILD: An Update

West Virginia State Rheumatology Society

R. Aggarwal

Update on the New ANA Classification System

Keck School of Medicine of USC

E. Taylor-Albert

Proton Pump Inhibitors in 2024: The Pros, the Cons and the Truth

Jefferson Health

P. Wong

How Does the Treatment of Behçet’s Disease Differ Based on Disease M…

Cleveland Clinic Rheumatology

G. Hatemi

GERD Diagnosis, Medical Management and Lifestyle Approaches to Treat…

Weill Cornell Medicine

F. Schnoll-Sussman, P. Katz, J. Haskin, R. Sharaiha, C. Newberry